Bia et al., 1982 - Google Patents
Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigsBia et al., 1982
- Document ID
- 12146848152043765149
- Author
- Bia F
- Lucia H
- Fong C
- Tarsio M
- Hsiung G
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
The pathogenesis and prevention of generalized infection and interstitial pneumonia due to cytomegalovirus (CMV) in inbred strain 2 guinea pigs were investigated. Eighteen animals inoculated with~ 107 50% tissue culture infective doses of virulent salivary gland-passaged …
- 241000701022 Cytomegalovirus 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviradae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4567042A (en) | Inactivated canine coronavirus vaccine | |
| US5948411A (en) | Stabilized live vaccine | |
| JP3993230B2 (en) | Improved modified BRSV live vaccine | |
| Dean et al. | Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge | |
| Porter et al. | Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice | |
| Bennett et al. | Studies on poxvirus infection in cats | |
| Osborn | Cytomegalovirus: pathogenicity, immunology, and vaccine initiatives | |
| Bagust | Comparison of the biological, biophysical and antigenic properties of four strains of infectious bovine rhinotracheitis herpesvirus | |
| Hsiung et al. | Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection | |
| US5047238A (en) | Adjuvants for vaccines | |
| Hubbard et al. | Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever | |
| Bia et al. | Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigs | |
| US4522810A (en) | Feline calicivirus vaccine | |
| US3674861A (en) | Live attenuated marek{40 s disease virus vaccine for poultry | |
| Jahrling et al. | Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells | |
| Jordan | Adverse effects of cytomegalovirus vaccination in mice | |
| CA1039651A (en) | Attenuation of cytomegalovirus | |
| Torres et al. | Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease | |
| De Maeyer et al. | Growth characteristics, interferon production and plaque formation with different lines of Edmonston measles virus | |
| US3925544A (en) | Bovine vaccines and methods of making and using same | |
| US3709782A (en) | Heteroploid cell lines | |
| JPH0555487B2 (en) | ||
| Chengappa et al. | Efficacy of a live Pasteurella multocida vaccine for the prevention of experimentally induced bovine pneumonic pasteurellosis | |
| Dietz Jr et al. | Enzootic and epizootic Venezuelan equine encephalomyelitis virus in horses infected by peripheral and intrathecal routes | |
| Sachs et al. | Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates |